Pharmacogentic factors influencing the metabolism of 13-cis retinoic acid
5203 L $$aThe administration of 13-cis retinoic acid (13cisRA) improves 3-year event free survival rates in children with high-risk neuroblastoma. However, more than half of patients suffer relapse within 3 years. A high degree of variability in UcisRA pharmacokinetics has been reported, suggesting...
| Main Author: | |
|---|---|
| Published: |
University of Newcastle upon Tyne
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.493211 |